Becton, Dickinson and Company (BDX) EPS Estimated At $2.43

January 19, 2018 - By Marguerite Chambers

 Becton, Dickinson and Company (BDX) EPS Estimated At $2.43
Investors sentiment decreased to 0.93 in Q3 2017. Its down 0.25, from 1.18 in 2017Q2. It fall, as 53 investors sold Becton, Dickinson and Company shares while 344 reduced holdings. 74 funds opened positions while 297 raised stakes. 197.53 million shares or 0.90% more from 195.76 million shares in 2017Q2 were reported.
Chem Savings Bank stated it has 4,175 shares or 0.09% of all its holdings. Iowa-based Dubuque Comml Bank Com has invested 0.1% in Becton, Dickinson and Company (NYSE:BDX). Wedgewood Pa holds 0.52% or 3,142 shares. Kentucky Retirement Systems Fund invested in 6,012 shares. 709 were accumulated by Clarivest Asset Mngmt Limited. Mitsubishi Ufj Trust & Bk accumulated 0.18% or 501,491 shares. Fjarde Ap owns 0.2% invested in Becton, Dickinson and Company (NYSE:BDX) for 54,059 shares. Mountain Pacific Investment Advisers Incorporated Id accumulated 4,875 shares. Utd Cap Fincl Advisers holds 183,334 shares. Sandy Spring Comml Bank holds 5,511 shares or 0.1% of its portfolio. Texas Yale Capital Corporation holds 7,343 shares. 443,845 are owned by Sei Investments. Toth Advisory Corporation, Virginia-based fund reported 24,444 shares. Dimensional Fund Advsr L P has invested 0.04% in Becton, Dickinson and Company (NYSE:BDX). Kanawha Capital Ltd Limited Liability Company has 62,534 shares.

Since August 9, 2017, it had 0 insider purchases, and 9 sales for $15.96 million activity. Tharby Linda M sold 4,695 shares worth $941,254. Strahlman Ellen R also sold $1.84 million worth of Becton, Dickinson and Company (NYSE:BDX) on Thursday, August 10. Mas Ribo Alberto also sold $1.50M worth of Becton, Dickinson and Company (NYSE:BDX) shares. $1.18M worth of stock was sold by Polen Thomas E Jr on Wednesday, August 9. The insider Sichak Stephen sold 11,787 shares worth $2.36M. 15,512 shares valued at $3.16 million were sold by COHEN GARY M on Monday, September 11.

Analysts expect Becton, Dickinson and Company (NYSE:BDX) to report $2.43 EPS on February, 1.They anticipate $0.10 EPS change or 4.29 % from last quarter’s $2.33 EPS. BDX’s profit would be $647.39M giving it 23.88 P/E if the $2.43 EPS is correct. After having $2.40 EPS previously, Becton, Dickinson and Company’s analysts see 1.25 % EPS growth. The stock increased 0.32% or $0.75 during the last trading session, reaching $232.12. About 1.10 million shares traded. Becton, Dickinson and Company (NYSE:BDX) has risen 12.32% since January 19, 2017 and is uptrending. It has underperformed by 4.38% the S&P500.

Becton, Dickinson and Company (NYSE:BDX) Ratings Coverage

Among 18 analysts covering Becton Dickinson (NYSE:BDX), 11 have Buy rating, 0 Sell and 7 Hold. Therefore 61% are positive. Becton Dickinson has $260.0 highest and $146 lowest target. $223.53’s average target is -3.70% below currents $232.12 stock price. Becton Dickinson had 46 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, November 9 by Jefferies. On Thursday, August 10 the stock rating was maintained by Barclays Capital with “Equal-Weight”. The stock of Becton, Dickinson and Company (NYSE:BDX) earned “Buy” rating by Stifel Nicolaus on Thursday, November 2. The stock of Becton, Dickinson and Company (NYSE:BDX) has “Buy” rating given on Friday, June 9 by Jefferies. The rating was maintained by Citigroup with “Neutral” on Thursday, February 4. The firm has “Buy” rating given on Monday, August 14 by Cowen & Co. The stock has “Hold” rating by RBC Capital Markets on Friday, November 3. The firm has “Buy” rating given on Tuesday, September 26 by Jefferies. Wells Fargo maintained Becton, Dickinson and Company (NYSE:BDX) rating on Tuesday, October 24. Wells Fargo has “Outperform” rating and $235 target. The stock of Becton, Dickinson and Company (NYSE:BDX) has “Buy” rating given on Friday, December 29 by Deutsche Bank.

Becton, Dickinson and Company develops, makes, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company has market cap of $61.84 billion. It operates in two divisions, BD Medical and BD Life Sciences. It has a 50.46 P/E ratio. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems.

More important recent Becton, Dickinson and Company (NYSE:BDX) news were published by: which released: “Salem Capital Management Inc Buys AT&T Inc, Cooper Tire & Rubber Co, Becton …” on January 16, 2018, also published article titled: “Ex-Dividend Reminder: Becton, Dickinson, Mid-America Apartment Communities and …”, published: “KeyBanc Initiates Becton, Dickinson And Co. With Bullish Stance” on January 05, 2018. More interesting news about Becton, Dickinson and Company (NYSE:BDX) was released by: and their article: “FDA warns 2nd company of ‘significant violations’ in lead tests” with publication date: January 12, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: